Cleared Traditional

VENOVALVE(TM) (K881234) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K881234 · Abbott Laboratories · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1988
Decision
84d
Days
Class 2
Risk

K881234 is an FDA 510(k) clearance for the VENOVALVE(TM). Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on June 13, 1988 after a review of 84 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

Submission Details

510(k) Number K881234 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 21, 1988
Decision Date June 13, 1988
Days to Decision 84 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 129d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 237
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K881234.
SAFESITE INJECTION SITE AND BLUNT CANNULA
K883638 · Baxter Healthcare Corp · Sep 1988
EXTENDED LIFE INJECTION SITE
K882007 · Baxter Healthcare Corp · Jun 1988
BLOOD/SOLUTION SET W/PRESSURE PUMP
K881321 · Baxter Healthcare Corp · Jun 1988
CHECK VALVE
K881052 · Baxter Healthcare Corp · May 1988
SECONDARY SOLUTION ADMINISTRATION SET W/SHEATH
K880482 · Baxter Healthcare Corp · Mar 1988
A SERIES OF 7 INCH CONTINUOUS INFUSION SETS
K874403 · Quinton, Inc. · Dec 1987